Previous Close | 7.14 |
Open | 7.22 |
Bid | 6.74 x 800 |
Ask | 7.37 x 2900 |
Day's Range | 7.00 - 7.44 |
52 Week Range | 5.00 - 7.88 |
Volume | |
Avg. Volume | 57,746 |
Market Cap | 237.609M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 1,014.29 |
EPS (TTM) | 0.01 |
Earnings Date | Aug 23, 2022 - Aug 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.57 |
Subscribe to Yahoo Finance Plus to view Fair Value for EDAP
First quarter 2022 revenue of approximately EUR 13.0 million (USD 14.5 million), an increase of 26% as compared to EUR 10.3 million (USD 12.4 million) for the first quarter 2021Four Focal One units sold in Q1 2022 versus zero in Q1 2021Strong cash position of $51.6 million as of March 31, 2022Company to host a conference call tomorrow, Wednesday, May 18, at 8:30 am ET LYON, France, May 17, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, anno
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31st, 2022 after the markets close on Tuesday, May 17th, 2022. An accompanying conference call and webcast will be hosted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, Ryan Rhodes, CEO of
AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will be showcasing and exhibiting its Focal One® Robotic High Intensity Focused Ultrasound (HIFU) platform at the upcoming Annual Meeting of the American Urological Association (AUA), the largest gathering of urologists worldwide, which will be held May 13th through 15th in New Or